First Horizon Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

First Horizon Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-656	Closed	-$16K	–	1605
2018 Q3	$16K	Hold	656	–	–	﹤0.01%	961
2018 Q2	$12K	Hold	656	–	–	﹤0.01%	1069
2018 Q1	$11K	Hold	656	–	–	﹤0.01%	981
2017 Q4	$8K	Hold	656	–	–	﹤0.01%	1111
2017 Q3	$10K	Hold	656	–	–	﹤0.01%	1017
2017 Q2	$10K	Hold	656	–	–	﹤0.01%	993
2017 Q1	$8K	Hold	656	–	–	﹤0.01%	1097
2016 Q4	$7K	Hold	656	–	–	﹤0.01%	1089
2016 Q3	$7K	Buy	656 +30	+5%	+$353	﹤0.01%	1079
2016 Q2	$6K	Buy	626 +380	+154%	+$3.92K	﹤0.01%	1088
2016 Q1	$2K	Hold	246	–	–	﹤0.01%	1267
2015 Q4	$3K	Sell	246 -143	-37%	-$2.39K	﹤0.01%	1147
2015 Q3	$6K	Hold	389	–	–	﹤0.01%	1141
2015 Q2	$8K	Buy	389 +18	+5%	+$358	﹤0.01%	1105
2015 Q1	$5K	Buy	371 +228	+159%	+$2.96K	﹤0.01%	1245
2014 Q4	$1K	Sell	143 -291	-67%	-$3.33K	﹤0.01%	1435
2014 Q3	$4K	Buy	434 +24	+6%	+$274	﹤0.01%	1307
2014 Q2	$4K	Hold	410	–	–	﹤0.01%	1284
2014 Q1	$4K	Hold	410	–	–	﹤0.01%	1155
2013 Q4	$6K	Buy	+410	New	+$6.89K	﹤0.01%	1065

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Horizon Advisors's MNTA Position: Q4 2018 in Review

First Horizon Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 656 shares — an estimated $16K sold.

First Horizon Advisors first reported a position in MNTA in Q4 2013 and held it in 20 quarters. The position peaked at $16K in Q3 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

First Horizon Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
First Horizon Advisors sold 656 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $16K.
First Horizon Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 20 quarters.
First Horizon Advisors's Momenta Pharmaceuticals, Inc. position peaked at $16K in Q3 2018.
158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on First Horizon Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.